New Combination Treatments: What Do They Mean for CLL Patients?
Combination treatments using drugs that target different CLL mechanisms have shown promising results for patients in clinical trials. And the great news is that some treatments that combine BTK and BCL2 inhibitors are now being approved as first line treatment options in Canada.